Journal of Fungi
In Vitro Terbinafine Susceptibility of Dermatophytes and Mycological Cure Outcomes from a Multicenter Phase III Onychomycosis Trial
Door Mahmoud Ghannoum, Erin Marie D. San Valentin en Amir Tavakkol.
Inhoud in het Engels
Abstract
Background
Dermatophyte infections, including onychomycosis, affect millions worldwide. Terbinafine, an allylamine antifungal, remains a foundational method of treatment.
Objective
We aim to evaluate the in vitro antifungal susceptibility of terbinafine against dermatophyte isolates obtained from patients participating in a Phase III onychomycosis clinical trial.